http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004041280-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3da0ce52a7e55d643cc0e08d1ee2d8c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f7c524b2862418c47d60755f1d91065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_862360d414d271c0f5695ef8bbdbb5c0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2003-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73a9d49b43e0964ef497b87059dd50d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb67520f3f6253e1232050685cfb199d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c664f739f52eb963bfbaac24ad99c435 |
| publicationDate | 2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2004041280-A1 |
| titleOfInvention | Composition for preventing secretion of immunoglobulin e-dependent histamine releasing factor |
| abstract | The present invention relates to a composition for inhibiting the secretion of an immunoglobulin E (IgE)-dependent histamine-releasing factor, and pharmaceutical use thereof. The composition of the present invention contains a benzimidazolic compound having proton pump inhibitor activity, as an active ingredient. Furthermore, the composition of the present invention may contain at least one substance selected from the group consisting of fenoctimine, oleic acid, catechin, scopadulciol, pentagalloyl glucose, bufalin, and macrolide antibiotic bafilomycin and concanamycin, all having proton pump inhibitor activity, as an additional active ingredient or a single active ingredient. The composition of the present invention can be advantageously used as a pharmaceutical composition for the prevention and treatment of various allergic diseases and malaria, which are caused by the IgE-dependent histamine-releasing factor. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010119102-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006051987-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1779848-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006051987-A1 |
| priorityDate | 2002-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 205.